
Tenet Healthcare (THC) Stock Forecast & Price Target
Tenet Healthcare (THC) Analyst Ratings
Bulls say
Tenet Healthcare's positive outlook is supported by its strategic investments in the USPI segment, which is characterized by faster growth, higher margins, and superior returns. Projections indicate that revenue from equity earnings is expected to rise in 2026 compared to 2025, demonstrating the company's financial growth potential. Furthermore, factors such as strong demand, an improved payer mix, diminishing operational pressures, and the transformation within the USPI segment collectively enhance the visibility of margin expansion across the organization.
Bears say
The analysis highlights concerns regarding Tenet Healthcare's impending financial challenges due to the anticipated expiration of subsidies, which may result in a significant loss of coverage for 80-85% of its patient population, thereby leading to a projected decline in utilization. The potential $220 million headwind to the Acute segment and a $30 million headwind to USPI emphasizes the substantial risks that could adversely affect revenue growth in 2026. Furthermore, despite a recent infusion of $148 million from non-recurring Medicaid state funds, this temporary boost raises skepticism about the sustainability of Tenet's financial performance amidst these mounting pressures.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Tenet Healthcare (THC) Analyst Forecast & Price Prediction
Start investing in Tenet Healthcare (THC)
Order type
Buy in
Order amount
Est. shares
0 shares